Back to Members Directory
easyXAFS LLC
Contact information may be available to logged in members.
Company Synopsis
easyXAFS brings fully automated X-ray absorption fine structure (XAFS) spectroscopy to the battery sector, delivering element-specific oxidation-state and local-structure information directly within development and manufacturing workflows. Our systems characterize battery precursors, electrode laminates, solid-state electrolytes, and complete pouch cells. Automated sample handling supports high-throughput screening and quality control, and operando measurements follow working cells through cycling and capacity fade. Teams can track transition-metal valence in NMC and other cathode chemistries, dopant and impurity speciation, and electrolyte structure on their own schedule, without waiting for synchrotron access.
easyXAFS is the originator and global leader in laboratory XAFS and X-ray emission spectroscopy (XES). Based in the Seattle area, the company created the modern laboratory XAFS spectrometer, turning a measurement once confined to synchrotron beamlines into a routine, in-house tool. Our instruments are installed at leading universities, national laboratories, and industrial R&D centers around the world. Through our XAFS on Demand mail-in service, organizations can obtain laboratory XAFS measurements with expert analysis for one-off projects, as routine access for repeated assays, or to prototype an R&D or QA process before requesting capital funding.
easyXAFS is the originator and global leader in laboratory XAFS and X-ray emission spectroscopy (XES). Based in the Seattle area, the company created the modern laboratory XAFS spectrometer, turning a measurement once confined to synchrotron beamlines into a routine, in-house tool. Our instruments are installed at leading universities, national laboratories, and industrial R&D centers around the world. Through our XAFS on Demand mail-in service, organizations can obtain laboratory XAFS measurements with expert analysis for one-off projects, as routine access for repeated assays, or to prototype an R&D or QA process before requesting capital funding.